Suppr超能文献

2,3,7,8-四氯二苯并对二恶英与2,2',4,4',5,5'-六氯联苯在小鼠肝脏中发生毒代动力学相互作用后细胞色素P450同工酶的诱导作用。

Induction of cytochrome P450 isoenzymes after toxicokinetic interactions between 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2,2',4,4',5,5'-hexachlorobiphenyl in the liver of the mouse.

作者信息

De Jongh J, DeVito M, Nieboer R, Birnbaum L, Van den Berg M

机构信息

Research Institute of Toxicology, Utrecht University, The Netherlands.

出版信息

Fundam Appl Toxicol. 1995 May;25(2):264-70. doi: 10.1006/faat.1995.1062.

Abstract

One group of male C57BL/6J mice received a single oral dose of 1 nmol 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)/kg. Six other groups received single oral doses of 100, 300, or 1000 mumol 2,2',4,4',5,5'-hexachlorobiphenyl (HxCB)/kg, alone or in combination with 1 nmol/kg TCDD. Liver deposition of both compounds was studied at Day 3 after dosage. Hepatic CYP1A1 and CYP1A2 protein levels and related 7-ethoxyresorufin-O-deethylation (EROD) and acetanilide 4-hydroxylation (ACOH) activities were also studied. A significant increase in the hepatic deposition of TCDD was observed in all three mixed dose groups but TCDD did not influence hepatic HxCB deposition. TCDD did increase both CYP1A1 and CYP1A2 protein levels. In the HxCB-treated groups, CYP1A2 levels were also increased in a dose-dependent way but CYP1A1 levels were not increased. CYP1A2 activities (ACOH), but not protein levels, in the TCDD groups cotreated with HxCB were higher than those in the group treated with TCDD alone. CYP1A1-dependent EROD activity and CYP1A2-dependent ACOH activity were induced in all treated dose groups. It is concluded that the present results do not confirm a direct role of CYP1A2 induction in the increase of hepatic TCDD levels by HxCB cotreatment in the mixed HxCB/TCDD dose groups. However, in this aspect, the discrepancy between CYP1A2 activities and protein levels remains to be explained.

摘要

一组雄性C57BL/6J小鼠经口单次给予1 nmol 2,3,7,8-四氯二苯并-对-二恶英(TCDD)/kg。其他六组分别经口单次给予100、300或1000 μmol 2,2',4,4',5,5'-六氯联苯(HxCB)/kg,单独给药或与1 nmol/kg TCDD联合给药。给药后第3天研究两种化合物在肝脏中的沉积情况。还研究了肝脏中CYP1A1和CYP1A2蛋白水平以及相关的7-乙氧基异吩恶唑酮-O-脱乙基酶(EROD)和对乙酰氨基酚4-羟化酶(ACOH)活性。在所有三个混合剂量组中均观察到TCDD在肝脏中的沉积显著增加,但TCDD不影响肝脏中HxCB的沉积。TCDD确实增加了CYP1A1和CYP1A2蛋白水平。在HxCB处理组中,CYP1A2水平也呈剂量依赖性增加,但CYP1A1水平未增加。与单独给予TCDD的组相比,联合给予HxCB及TCDD的组中CYP1A2活性(ACOH)升高,但蛋白水平未升高。所有处理剂量组中均诱导了CYP1A1依赖性EROD活性和CYP1A2依赖性ACOH活性。得出的结论是,目前的结果并未证实CYP1A2诱导在混合HxCB/TCDD剂量组中通过联合给予HxCB增加肝脏TCDD水平方面具有直接作用。然而,在这方面,CYP1A2活性和蛋白水平之间的差异仍有待解释。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验